Diagnostica Stago STA Noplastine CI, 10 ml vial. In-Vitro Diagnostic for determination of the prothrombin time (PT) in plasma. REF: 00666 The STA - Noplastine CI kits provide reagents for the determination of the prothrombin time (PT) in plasma with STA-R, STA Compact and STA Satellite. (In the USA this procedure has been assigned to the moderate complexity category per CLIA 1988 - CDC Analyte Code 4922; CDC Test System Codes 4677 and 4875).
FDA Recall Z-2994-2018 · Posted None
Advertisement
Recalling FirmDiagnostica Stago, Inc.
Recall StatusTerminated
Product CodeGJS
Date Initiated2018-07-24
Date Terminated2020-05-18
Product Quantity5 kits
Reason for Recall
QC values outside of the assigned ranges (prolonged Prothrombin time / decreased PT %)
Firm Action
Diagnostica Stago issued notification on July 24, 2018 to US Customers provided the reason for the notification, actions to be taken to mitigate the risk.
Action: If you have in your laboratory, any of the lots among those listed in the appendix, we are asking you to: If it is not already done, run a Quality Control test at every change of vial.
Return to your Stago affiliate, by fax or e-mail, the enclosed form completed and confirming that you have read this letter.
Questions contact Stago Hotline (1-800-725-0607)
Root Cause
Device Design
Distribution Pattern
Nationwide
Related FDA 510(k) Records
Devices referenced by this recall via K-numbers.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement